Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitis

ClinicalTrials.gov ID: NCT03356977

Public ClinicalTrials.gov record NCT03356977. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 4:20 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A PHASE 4, MULTICENTER, OPEN-LABEL SAFETY STUDY OF CRISABOROLE OINTMENT 2% IN CHILDREN AGED 3 MONTHS TO LESS THAN 24 MONTHS WITH MILD TO MODERATE ATOPIC DERMATITIS

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This 4-week study will evaluate the safety, pharmacokinetics (PK), and efficacy of crisaborole ointment 2%, applied twice daily (BID) in subjects who are 3 months to less than 24 months of age with mild-to-moderate AD.

Study identification

NCT ID
NCT03356977
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Pfizer
Industry
Enrollment
137 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
3 Months to 23 Months
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 15, 2018
Primary completion
Apr 11, 2019
Completion
Apr 11, 2019
Last update posted
Oct 9, 2019

2018 – 2019

United States locations

U.S. sites
23
U.S. states
16
U.S. cities
20
Facility City State ZIP Site status
Burke Pharmaceutical Research Hot Springs Arkansas 71913
Rady Children's Hospital - San Diego/University of California, San Diego San Diego California 92123
Rady Children's Hospital San Diego California 92123
University of California, San Francisco San Francisco California 94115
IMMUNOe Research Centers Thornton Colorado 80233
Baumann Cosmetic and Research Institute Miami Florida 33137
DS Research Louisville Kentucky 40241
Craig A. Spiegel, M.D. Bridgeton Missouri 63044
Skin Specialists, PC Omaha Nebraska 68144
Ohio Pediatric Research Association, Inc. Dayton Ohio 45414
Oklahoma State University - Center for Health Sciences Tulsa Oklahoma 74127
Oregon Health & Science University Portland Oregon 97239
Penn State Hershey Medical Center Hershey Pennsylvania 17033
DermResearch, Inc. Austin Texas 78759
Texas Dermatology and Laser Specialists San Antonio Texas 78218
Tanner Clinic Layton Utah 84041
Jordan Valley Dermatology Center West Jordan Utah 84088
Timber Lane Allergy & Asthma Research, LLC South Burlington Vermont 05403
PI-Coor Clinical Research, LLC Burke Virginia 22015
Pediatric Associates of Charlottesville, PLC Charlottesville Virginia 22902
Pediatric Research of Charlottesville, LLC (Regulatory Only) Charlottesville Virginia 22902
Pediatric Research of Charlottesville, LLC Charlottesville Virginia 22902
Dermatology Specialists of Spokane Spokane Washington 99202

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03356977, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 9, 2019 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03356977 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →